What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?

Journal of Neurosurgery

Volumn 108, Issue 1, 2008, Pages 92-96

  Evans, D Gareth R ^a   Ramsden, Richard T ^b   Shenton, Andrew ^a   Gokhale, Carolyn ^a   Bowers, Naomi ^a   Huson, Susan M ^a   Wallace, Andrew J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Mosaic mutation; Neurofibromatosis type 2; Unilateral vestibular schwannoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOSAICISM; MUTATOR GENE; NEURILEMOMA; NEUROFIBROMATOSIS; NEUROGENIC TUMOR; NF2 GENE; PRIORITY JOURNAL; RISK ASSESSMENT; VESTIBULAR NERVE;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, NEUROFIBROMATOSIS 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MIDDLE AGED; MOSAICISM; NEUROMA, ACOUSTIC; PEDIGREE;

EID: 38149052796     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/JNS/2008/108/01/0092     Document Type: Article

References (14)

1. Aghi M, Kluwe L, Webster MT, Jacoby LB, Barker FG II, Ojemann RG, et al: Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype. J Neurosurg 104:201-207, 2006
2. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DGR: Evaluation of diagnostic criteria for neurofibromatosis 2. Neurology 59:1759-1765, 2002
3. Bijlsma E, Wallace AJ, Evans DG: Misleading linkage results in a family with mosaic NF2. J Med Genet 34:934-936, 1997
4. Evans DG, Baser ME, O'Reilly B, Rowe J, Gleeson M, Saeed S, et al: Management of the patient and family with Neurofibromatosis 2: a consensus conference statement. Br J Neurosurg 19: 5-12, 2005
5. Evans DG, Huson S, Donnai D, Neary W, Blair V, Newton V, et al: A clinical study of type 2 neurofibromatosis. Q J Med 84: 603-618, 1992
6. Evans DG, Lye R, Neary W, Black G, Wallace A, Strachan T, et al: The probability of bilateral disease in individuals presenting with a unilateral vestibular schwannoma. J Neurol Neurosurg Psychiatry 66:764-767, 1999
7. Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R: Incidence of vestibular schwannoma and neurofibromatosis 2 in the north west of England over a 10 year period: higher incidence than previously thought. Otol Neurotol 26:93-97, 2005
8. Evans DG, Ramsden RT, Shenton A, Gokhale C, Bowers NL, Huson SM, et al: Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification. J Med Genet 44:424-428, 2007
9. Evans DG, Wallace AJ, Wu CL, Trueman L, Ramsden RT, Strachan T: Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis. Am J Hum Genet 63:727-736, 1998
10. Kluwe L, Mautner VF, Heinrich B, Dezube R, Jacoby LB, Friedrich RE, et al: Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40:109-114, 2003
11. Moyhuddin A, Baser ME, Watson C, Purcell S, Ramsden RT, Heiberg A, et al: Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J Med Genet 40:459-463, 2003
12. Mohyuddin A, Neary WJ, Wallace AJ, Purcell S, Wu C-L, Reid H, et al: Molecular genetic exclusion of NF2 in young patients diagnosed with a unilateral vestibular schwannoma. J Med Genet 39:315-322, 2002
13. Tos M, Charabi S, Thomsen J: Incidence of vestibular schwannomas. Laryngoscope 109:736-740, 1999
14. Wallace AJ, Watson CJ, Howard E, Evans DGR, Elles RG: Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis and loss of heterozygosity analysis. Genet Test 8:368-380, 2004